Joshua Alexander Tamaroff

CIK 1705548 · last filed 2021-02-18

Joshua Alexander Tamaroff is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for ORGO, was dated Feb 18, 2021. Current disclosed insider exposure totals $51.9K across reported positions. 12 SEC filings were submitted jointly with David F Burgstahler.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$51.9K

Companies

3

Total Filings

6

Lifetime Open-Market Net

$0

Filer Profile

Reported Address

C/O AVISTA CAPITAL PARTNERS
65 EAST 55TH STREET, 18TH FLOOR
NEW YORK, NY 10022

Related Filers

David F Burgstahler — 12 joint filings, latest 2024-07-02

Thompson Dean — 7 joint filings, latest 2024-07-02

Avista Capital Partners (Offshore) V, L.P. — 6 joint filings, latest 2024-07-02

Avista Capital Partners V, L.P. — 6 joint filings, latest 2024-07-02

Avista Capital Managing Member, LLC — 5 joint filings, latest 2019-08-06

Avista Capital Partners (Offshore) III, L.P. — 5 joint filings, latest 2019-08-06

Avista Acquisition GP LLC II — 2 joint filings, latest 2022-12-13

Avista Capital Partners (Offshore), L.P. — 2 joint filings, latest 2017-06-19

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ORGO	Director	30,364	$1.71	$51.9K	$0	2	2021-02-18
OptiNose, Inc. (OPTN) Delisted	Director	—	$9.60	—	$0	3	2020-06-12
Organogenesis Holdings Inc. (AHPAW) Delisted	Director	—	$0.69	—	$0	1	2018-12-12

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-02-18	ORGO	Grant (A)	+11,800	$0	EDGAR
2020-06-12	OptiNose, Inc. (OPTN) Delisted	Grant (A)	—	$0	EDGAR
2020-04-24	ORGO	Grant (A)	+18,564	$0	EDGAR
2019-06-10	OptiNose, Inc. (OPTN) Delisted	Grant (A)	—	$0	EDGAR
2018-12-12	Organogenesis Holdings Inc. (AHPAW) Delisted	Grant (A)	—	$0	EDGAR
2018-06-11	OptiNose, Inc. (OPTN) Delisted	Grant (A)	—	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.